Medicinova Capital Expenditures (CapEx) Growth & History (MNOV)
Medicinova's capital expenditures (capex) was $2,899 for fiscal 2025.
View full Medicinova company overviewMedicinova annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $2,899 | $2,004 | +223.91% |
| 2024 | 2024-12-31 | $895 | −$20,404 | −95.80% |
| 2023 | 2023-12-31 | $21,299 | $16,289 | +325.13% |
| 2022 | 2022-12-31 | $5,010 | −$23,722 | −82.56% |
| 2021 | 2021-12-31 | $28,732 | −$7,760 | −21.26% |
| 2020 | 2020-12-31 | $36,492 | $25,220 | +223.74% |
| 2019 | 2019-12-31 | $11,272 | $1,072 | +10.51% |
| 2018 | 2018-12-31 | $10,200 | — | — |
| 2016 | 2016-12-31 | $84,483 | −$2.2M | −96.36% |
| 2015 | 2015-12-31 | $2.3M | $2.3M | +65752.97% |
| 2014 | 2014-12-31 | $3,523 | −$38,031 | −91.52% |
| 2013 | 2013-12-31 | $41,554 | −$41,824 | −50.16% |
| 2012 | 2012-12-31 | $83,378 | $77,293 | +1270.22% |
| 2011 | 2011-12-31 | $6,085 | −$12,474 | −67.21% |
| 2010 | 2010-12-31 | $18,559 | $2,112 | +12.84% |
| 2009 | 2009-12-31 | $16,447 | — | — |
Medicinova quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0 | $0 | — |
| Q1 2026 | 2026-03-31 | $10,825 | $10,825 | — |
| Q4 2025 | 2025-12-31 | $0 | — | — |
| Q3 2025 | 2025-09-30 | $2,899 | $2,893 | +48216.67% |
| Q2 2025 | 2025-06-30 | $0 | — | — |
| Q1 2025 | 2025-03-31 | $0 | — | — |
| Q3 2024 | 2024-09-30 | $6 | −$2,738 | −99.78% |
| Q3 2023 | 2023-09-30 | $2,744 | — | — |
| Q3 2021 | 2021-09-30 | $2,938 | $1,748 | +146.89% |
| Q4 2020 | 2020-12-31 | $32,698 | $25,439 | +350.45% |
| Q3 2020 | 2020-09-30 | $1,190 | $1,190 | — |
| Q2 2020 | 2020-06-30 | $10 | −$2,050 | −99.51% |
| Q1 2020 | 2020-03-31 | $2,594 | $641 | +32.82% |
| Q4 2019 | 2019-12-31 | $7,259 | $7,252 | +103600.00% |
| Q3 2019 | 2019-09-30 | $0 | $0 | — |
| Q2 2019 | 2019-06-30 | $2,060 | $437 | +26.93% |
| Q1 2019 | 2019-03-31 | $1,953 | −$6,631 | −77.25% |
| Q4 2018 | 2018-12-31 | $7 | — | — |
| Q3 2018 | 2018-09-30 | $0 | — | — |
| Q2 2018 | 2018-06-30 | $1,623 | — | — |
| Q1 2018 | 2018-03-31 | $8,584 | — | — |
| Q4 2016 | 2016-12-31 | $17,640 | — | — |
| Q3 2016 | 2016-09-30 | $33,709 | — | — |
| Q2 2016 | 2016-06-30 | $11,129 | — | — |
| Q1 2016 | 2016-03-31 | $22,005 | — | — |
| Q4 2014 | 2014-12-31 | $0 | — | — |
| Q3 2014 | 2014-09-30 | $0 | −$15,008 | — |
| Q2 2014 | 2014-06-30 | $0 | — | — |
| Q1 2014 | 2014-03-31 | $3,523 | — | — |
| Q3 2013 | 2013-09-30 | $15,008 | −$18,832 | −55.65% |
| Q4 2012 | 2012-12-31 | $202 | — | — |
| Q3 2012 | 2012-09-30 | $33,840 | $33,840 | — |
| Q2 2012 | 2012-06-30 | $41,312 | — | — |
| Q1 2012 | 2012-03-31 | $8,024 | — | — |
| Q3 2011 | 2011-09-30 | $0 | −$7,200 | — |
| Q3 2010 | 2010-09-30 | $7,200 | — | — |
Medicinova capital expenditures (capex) trends
Over the last five fiscal years, Medicinova's capital expenditures (capex) decreased from $36,492 to $2,899, a change of −$33,593. The latest reported quarter, Q2 2026, shows $0.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Medicinova source filings ↗